IDEAYA Biosciences, Inc. (IDYA)
36.11
+0.05
(+0.14%)
USD |
NASDAQ |
Oct 09, 16:00
35.60
-0.51
(-1.41%)
After-Hours: 20:00
IDEAYA Biosciences Net Income (Quarterly) : -112.45M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -112.45M |
| March 31, 2026 | -98.54M |
| December 31, 2025 | -83.27M |
| September 30, 2025 | 119.24M |
| June 30, 2025 | -77.49M |
| March 31, 2025 | -72.18M |
| December 31, 2024 | -130.31M |
| September 30, 2024 | -51.82M |
| June 30, 2024 | -52.77M |
| March 31, 2024 | -39.57M |
| December 31, 2023 | -33.96M |
| September 30, 2023 | -27.44M |
| June 30, 2023 | -27.93M |
| March 31, 2023 | -23.64M |
| December 31, 2022 | -24.20M |
| September 30, 2022 | 1.615M |
| June 30, 2022 | -22.06M |
| Date | Value |
|---|---|
| March 31, 2022 | -14.01M |
| December 31, 2021 | -18.21M |
| September 30, 2021 | -11.58M |
| June 30, 2021 | -10.95M |
| March 31, 2021 | -9.021M |
| December 31, 2020 | -5.135M |
| September 30, 2020 | -4.926M |
| June 30, 2020 | -12.39M |
| March 31, 2020 | -12.04M |
| December 31, 2019 | -10.78M |
| September 30, 2019 | -10.97M |
| June 30, 2019 | -10.66M |
| March 31, 2019 | -9.569M |
| December 31, 2018 | -8.562M |
| September 30, 2018 | -13.05M |
| June 30, 2018 | -6.995M |
| March 31, 2018 | -5.737M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 51.29M |
| Xencor, Inc. | -21.73M |
| BioMarin Pharmaceutical, Inc. | 44.76M |
| MediciNova, Inc. | -2.314M |
| Viking Therapeutics, Inc. | -128.02M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 8.857M |
| Total Expenses (Quarterly) | 121.31M |
| EPS Diluted (Quarterly) | -1.222 |
| Enterprise Value | 2.680B |
| Gross Profit Margin (Quarterly) | 87.21% |
| Profit Margin (Quarterly) | -1.27K% |
| Earnings Yield | -5.38% |
| Normalized Earnings Yield | -5.381 |